Zakad Produkcyjny Firmy Servier w Polsce Anpharm Revenue and Competitors

We are one of eleven Manufacturing Site of the Servier Group, and at the same time one of the first original innovator companies manufacturing drugs in Poland. Using modern technologies and operating in an environment of strict quality requirements, we are aware that delivering drugs of the highest quality to our patients and the safety of our employees is our mission.\nFor more than 20 years we have experience in the manufacture medicines for the Polish market and also for export.\nOur portfolio contains a range of finished and semi-finished products.\n\nToday, almost all of the Servier Group’s products sold in Poland are produced by our site. 40% of the products manufactured by us are destined for export to 9 European countries (France, Croatia, Slovenia, Slovakia, Czech Republic, Lithuania, Latvia, Estonia and Serbia).\n\nThe consistent, significant financial investment of Servier Group and the transfer of modern technology enabled the dynamic development of our manufacturing site. Over 20 years we have increased our production volume by 650% - from 4 million to nearly 26 million packages every year, gradually increasing the employment (from 60 to over 160 in 2016). Every day we produce 5 million tablets of the highest quality. Annually, it amounts to 1 billion 200 million tablets.\n\nWe were the first drug-producing manufacture in Poland to receive GMP Certificate - Good Manufacture Practice (in 2003 - license then renewed in 2009, 2011 and 2014) and one of the first pharmaceutical companies in Poland which granted ISO 50001 certificate for energy management system (Certificate granted in 20016).\n\nREPORT A SIDE EFFECT \nIf you think you may have a health problem related to a Servier product or any other Servier health product, you can contact us at any time and report it to us at https://www.servier.pl/